ANI Pharma Launches Carbamazepine ER Capsules in US
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
MUMBAI, India and NAPLES, Fla., April 7, 2026 Lupin Limited has received approval from the U.S. Food and Drug...
